Antiplatelet effect of the pyrimido-pyrimidinic derivative RA-642
- 15 August 1991
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 63 (4) , 463-468
- https://doi.org/10.1016/0049-3848(91)90233-m
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodPublished by Elsevier ,2002
- Superoxide anions enhance platelet adhesion and aggregationBritish Journal of Pharmacology, 1989
- Dipyridamole inhibits lipid peroxidation and scavenges oxygen radicalsLipids, 1989
- Role of plasma adenosine in the antiplatelet action of hl 725, a potent inhibitor of camp phosphodiesterase: Species differences.Thrombosis Research, 1987
- Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dillazep and the camp phosphodiesterase inhibitor, RA 233Thrombosis Research, 1986
- RA-642Drugs of the Future, 1983
- Stimulation of sympathetic cardiovascular centres by RA 642, a new pyrimido-pyrimidine derivativeNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976
- RA 642, a pyrimido-pyrimidine-derivative with vasodilating and hypertensive potencyNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976
- Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: Possible explanation of mechanism of inhibition of platelet functionLife Sciences, 1975
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965